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Much progress has been made in
understanding the developmental
roles of Eph receptor tyrosine
kinases and their membrane-bound
ligands, ephrins. Interactions
between these molecules fall largely
into two classes: EphA receptors (of
which there are eight family
members) bind promiscuously to
glycosylphosphatidylinositol (GPI)-
anchored ephrin-A ligands
(five members), whereas EphB
receptors (six members) bind to
transmembrane ephrin-B ligands
(five members) [1]; see [2] for
nomenclature. Functional analyses
have revealed key roles for these
proteins in the regulation of repulsion
or adhesion responses that guide
axons and cells along specific
pathways (reviewed in [3,4]), restrict
cell intermingling [5] and underlie
remodelling of blood vessels [6,7].
Understanding the function of these
molecules requires knowledge of
their developmental expression
patterns; an important and widely
used technique for this has been the
use of fusions comprising the
extracellular domain of Eph receptors
or ephrins and alkaline phosphatase
or the Fc portion of IgG (IgG-Fc).
Because of the promiscuous binding
between members of each class of
Eph receptors and members of their
corresponding class of ligands, the
soluble fusion proteins can detect
expression of the corresponding class
of ephrins or Eph receptors by whole-
mount staining of embryos. This
technique has revealed gradients of
ephrin expression in the tectum that
underlie topographic mapping [8,9],
and a general complementary
expression of Eph receptors and
ephrins, which suggests a role for
these proteins in compartmentalising
the embryo [1]. Although in situ
hybridisation confirmed the
existence of gradients and
complementarity in the expression of
specific Eph-receptor and ephrin
mRNAs, it has also revealed some
overlaps in expression [7,10,11]. This
discrepancy raises the question of
whether the patterns detected by the
fusion proteins give an accurate
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Figure 1
(a–j) The left and right columns show wild-
type and eA5-transgenic mouse embryos,
respectively, stained with various reagents to
detect Eph receptors or ephrins (as indicated).
(a–d) Whole 9.5–10 day old embryos and
higher power views of (e–h) the tail bud and
(i,j) the midbrain are shown. Published
methods were used to stain with Fc fusion
proteins [1] and the anti-EphA4 antibody [15].
M, midbrain; hb, hindbrain; di, diencephalon; t,
tail bud; s, somites. (k) Diagram illustrating the
gradients of ephrin-A and EphA-receptor
expression and the location at which ephrin
has been fully masked by the Eph receptor
(solid arrow in (i,k)). (l) After transgenic
expression of ephrin-A5, the location at which
ephrin-A proteins have been fully masked has
shifted anteriorly (solid arrow in j,l) compared
with the position in wild-type embryos (dotted
arrow). A, anterior; P, posterior.
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picture of the expression domains of
Eph receptors and ephrins.
During studies of ephrin function,
we generated a transgenic line of
mice (termed eA5 transgenic) in
which a β-actin promoter drives
ubiquitous ectopic expression of
ephrin-A5. We stained control
(Figure 1a) and transgenic
(Figure 1b) embryos using EphA4–Fc
and detected ectopic expression of
ephrin-A protein throughout eA5-
transgenic embryos, except at specific
sites such as the tail mesoderm and
the hindbrain. Because the latter are
known sites for the expression of
EphA receptors, we attempted to
detect EphA receptor proteins by
staining embryos with ephrin-A5–Fc.
We found that, compared with control
embryos (Figure 1c), the detection of
EphA receptors in eA5-transgenic
embryos (Figure 1d) was severely
diminished in many tissues, including
the tail mesoderm (see also
Figure 1e,f), the dorsal part of
somites, the diencephalon and the
anterior midbrain. One explanation
for this result is that EphA receptors
were bound to membrane-bound
ephrin-A5, and were thus masked
from the soluble ephrin-A5 fusion
protein, which was at a lower
effective concentration. Alternatively,
an increased turnover of activated
receptors could have led to lower
levels of EphA receptor at sites of
overlap. To distinguish between
these two possibilities, we used an
antibody against the intracellular
domain of EphA4 and found that
there were similar levels of EphA4
protein in, for example, the tail
mesoderm of control and eA5-
transgenic embryos (Figure 1g,h).
Although some sites of EphA
expression were masked by
ectopically expressed ephrin-A5,
others, such as the hindbrain, were
not. Similarly, endogenous EphA
receptors masked ephrin-A5 in some
sites but not in others. This may
reflect the relative concentrations of
Eph receptor and ephrin, such that
only the component present in
excess over the other is detected.
The staining patterns in the
midbrain are consistent with this.
Ephrin-A5 and ephrin-A2 are
expressed in a posterior–anterior
gradient in the midbrain [8,9], and
there is a counter-gradient of the
corresponding receptors [11].
Detection with EphA4–Fc revealed
this ephrin-A gradient and a sharp
anterior boundary. Compared with
control embryos (Figure 1i), the
boundary is more anterior in eA5-
transgenic embryos (Figure 1j)
because the elevation of ephrin-A5
expression shifts the position at
which it is masked by the EphA
receptors (Figure 1k,l).
These data indicate that at sites
of overlap, Eph receptors and
ephrins are largely bound to each
other, possibly by clustering to sites
of cell contact [12]. Although staining
with Eph and ephrin fusion proteins
has provided initial clues to their
expression patterns, it is important to
appreciate that this technique
exaggerates the complementarity.
Overlapping expression is likely to
be of functional significance because
in the retina it leads to persistent
Eph-receptor activation [11], which
through desensitisation of a repulsion
response is required for topographic
mapping [13]. Overlapping
expression also occurs in endothelial
cells [7], and it is possible that
persistent activation of Eph receptors
underlies an adhesion response [14].
It is therefore essential to detect any
sites of overlapping expression by in
situ hybridisation and
immunocytochemistry.
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